1. Home
  2. CE

as of 04-02-2026 3:46pm EST

$64.05
+$0.50
+0.78%
Stocks Industrials Major Chemicals Nasdaq

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Founded: 1918 Country:
United States
United States
Employees: N/A City: IRVING
Market Cap: 5.6B IPO Year: 2004
Target Price: $61.69 AVG Volume (30 days): 2.6M
Analyst Decision: Buy Number of Analysts: 16
Dividend Yield:
0.19%
Dividend Payout Frequency: N/A
EPS: -10.64 EPS Growth: 23.62
52 Week Low/High: $35.13 - $67.82 Next Earning Date: 05-05-2026
Revenue: $9,544,000,000 Revenue Growth: -7.16%
Revenue Growth (this year): 1.27% Revenue Growth (next year): 3.39%
P/E Ratio: -6.03 Index: N/A
Free Cash Flow: 803.0M FCF Growth: +51.22%

AI-Powered CE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 74.23%
74.23%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 17, 2026 · 100% conf.

AI Prediction BUY

1D

+5.17%

$56.22

Act: +2.64%

5D

+9.32%

$58.43

Act: -0.67%

20D

+11.16%

$59.41

Price: $53.45 Prob +5D: 100% AUC: 1.000
0001306830-26-000016

ce-202602170001306830false00013068302026-02-172026-02-170001306830us-gaap:CommonStockMember2026-02-172026-02-170001306830ce:EURSeniorUnsecuredNotesDue2026Member2026-02-172026-02-170001306830ce:EURSeniorUnsecuredNotesDue2027Member2026-02-172026-02-170001306830ce:EURSeniorUnsecuredNotesDue2028Member2026-02-172026-02-170001306830ce:EURSeniorUnsecuredNotesDue2029Member2026-02-172026-02-170001306830ce:EURSeniorUnsecuredNotesDue2031Member2026-02-172026-02-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026

CELANESE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware001-3241098-0420726

(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (972) 443-4000

N/A

(Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange

4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange 2.125% Senior Notes due 2027CE /27The New York Stock Exchange 0.625% Senior Notes due 2028CE /28The New York Stock Exchange 5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange 5.000% Senior Notes due 2031CE /31The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 1

Item 2.02 Results of Operations and Financial Condition On February 17, 2026, Celanese Corporation (the "Company") issued a press release reporting the financial results for its fourth quarter and full year 2025. A copy of the press release is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. Each Non-US GAAP financial measure appearing in the press release is accompanied by the most directly comparable US GAAP financial measure and is reconciled to the most comparable US GAAP financial measure in Exhibit 99.2, which includes other supplemental information of interest to investors, analysts and other parties, including the reasons why management believes such Non-US GAAP financial measures provide useful information to investors, and which is incorporated herein solely for purposes of this Item 2.02 disclosure. Item 9.01 Financial Statements and Exhibits (d) The following exhibits are being furnished herewith:

Exhibit Number Description

99.1Press Release dated February 17, 2026*

99.2Non-US GAAP Financial Measures and Supplemental Information dated February 17, 2026*

104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101)

*    In connection with the disclosure set forth in Item 2.02, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. 2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELANESE CORPORATION

By:/s/ ASHLEY B. DUFFIE Name: Ashley B. Duffie Title:  Senior Vice President, General Counsel and

2025
Q3

Q3 2025 Earnings

8-K

Nov 6, 2025

0001306830-25-000217

ce-202511060001306830false00013068302025-11-062025-11-060001306830us-gaap:CommonStockMember2025-11-062025-11-060001306830ce:EURSeniorUnsecuredNotesDue2026Member2025-11-062025-11-060001306830ce:EURSeniorUnsecuredNotesDue2027Member2025-11-062025-11-060001306830ce:EURSeniorUnsecuredNotesDue2028Member2025-11-062025-11-060001306830ce:EURSeniorUnsecuredNotesDue2029Member2025-11-062025-11-060001306830ce:EURSeniorUnsecuredNotesDue2031Member2025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025

CELANESE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware001-3241098-0420726

(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (972) 443-4000

N/A

(Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange

4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange 2.125% Senior Notes due 2027CE /27The New York Stock Exchange 0.625% Senior Notes due 2028CE /28The New York Stock Exchange 5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange 5.000% Senior Notes due 2031CE /31The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 1

Item 2.02 Results of Operations and Financial Condition On November 6, 2025, Celanese Corporation (the "Company") issued a press release reporting the financial results for its third quarter 2025. A copy of the press release is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. Each Non-US GAAP financial measure appearing in the press release is accompanied by the most directly comparable US GAAP financial measure and is reconciled to the most comparable US GAAP financial measure in Exhibit 99.2, which includes other supplemental information of interest to investors, analysts and other parties, including the reasons why management believes such Non-US GAAP financial measures provide useful information to investors, and which is incorporated herein solely for purposes of this Item 2.02 disclosure. Item 9.01 Financial Statements and Exhibits (d) The following exhibits are being furnished herewith:

Exhibit Number Description

99.1Press Release dated November 6, 2025*

99.2Non-US GAAP Financial Measures and Supplemental Information dated November 6, 2025*

104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101)

*    In connection with the disclosure set forth in Item 2.02, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. 2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELANESE CORPORATION

By:/s/ ASHLEY B. DUFFIE Name: Ashley B. Duffie Title:  Senior Vice President, General Counsel and Corporate Secretary

2025
Q2

Q2 2025 Earnings

8-K

Aug 11, 2025

0001306830-25-000171

ce-202508110001306830false00013068302025-08-112025-08-110001306830us-gaap:CommonStockMember2025-08-112025-08-110001306830ce:EURSeniorUnsecuredNotesDue2026Member2025-08-112025-08-110001306830ce:EURSeniorUnsecuredNotesDue2027Member2025-08-112025-08-110001306830ce:EURSeniorUnsecuredNotesDue2028Member2025-08-112025-08-110001306830ce:EURSeniorUnsecuredNotesDue2029Member2025-08-112025-08-110001306830ce:EURSeniorUnsecuredNotesDue2031Member2025-08-112025-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2025

CELANESE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware001-3241098-0420726

(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (972) 443-4000

N/A

(Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange

4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange 2.125% Senior Notes due 2027CE /27The New York Stock Exchange 0.625% Senior Notes due 2028CE /28The New York Stock Exchange 5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange 5.000% Senior Notes due 2031CE /31The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 1

Item 2.02 Results of Operations and Financial Condition On August 11, 2025, Celanese Corporation (the "Company") issued a press release reporting the financial results for its second quarter 2025. A copy of the press release is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. Each Non-US GAAP financial measure appearing in the press release is accompanied by the most directly comparable US GAAP financial measure and is reconciled to the most comparable US GAAP financial measure in Exhibit 99.2, which includes other supplemental information of interest to investors, analysts and other parties, including the reasons why management believes such Non-US GAAP financial measures provide useful information to investors, and which is incorporated herein solely for purposes of this Item 2.02 disclosure. Item 9.01 Financial Statements and Exhibits (d) The following exhibits are being furnished herewith:

Exhibit Number Description

99.1Press Release dated August 11, 2025*

99.2Non-US GAAP Financial Measures and Supplemental Information dated August 11, 2025*

104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101)

*    In connection with the disclosure set forth in Item 2.02, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. 2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CELANESE CORPORATION

By:/s/ ASHLEY B. DUFFIE Name: Ashley B. Duffie Title:  Senior Vice President, General Counsel and Corporate Secretary

D

Share on Social Networks: